Stage 4
Manufacturing
FDA-registered and ISO 13485-certified device production at Ranfac. This is the existing Ranfac CDMO offering — the manufacturing operation that the rest of Forge feeds into.
Ranfac has manufactured medical devices and components under FDA and ISO oversight for decades. Stage 4 isn't a new product — it's the existing manufacturing P&L, contextualized as the natural destination for Forge customers whose devices are a Ranfac fit. Programs that came through Stage 2 and Stage 3 arrive with their DHF already in Ranfac's manufacturing format, capacity already confirmed, and a pre-priced quote in hand.
What manufacturing at Ranfac looks like
$250K–$2M first-year purchase order. $1M–$5M annual revenue at maturity for established programs.
Standard CDMO economics — 20–35% gross margin depending on complexity, volume, and contract structure.
FDA 21 CFR 820, ISO 13485, ISO 14971 risk management. Audit-ready by design, not by scramble.
For programs that came through Forge: weeks from Stage 3 close to first article. For external programs: standard 8–16 week transfer.
Manufacturing Readiness Package
Customers who complete Stage 3 Design Transfer at Ranfac arrive at Stage 4 with a complete Readiness Package: pre-priced quote (estimator-validated, 60–90 day expiry), capacity confirmed for the planned ramp, validated supplier list, predicted yield, and time-to-first-article. No additional discovery work needed — the program is ready to schedule.
Talk to Ranfac manufacturing
Whether you're coming through Forge or bringing an existing program for transfer, the path starts with a conversation about scope and timeline.